contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


patent-application-for-combined-pef-and-vi-treatment

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Analytiker

Lucas Mattsson

OptiCept Technologies förser livsmedels-och växtindustrin med teknologiska lösningar som används för att öka hållbarheten för diverse råvaror. Bolaget arbetar med biologiska processer som ger en ökad extraktion ur råvaran, minskat avfall samt bibehållen smak, doft, färg, näringsinnehåll. Bolaget har en patenterad teknologi inom PEF (pulsed electric field) och VI (Vacuum Infusion). Bolaget säljer sina produkter på en global nivå. Huvudkontoret ligger i Lund.

OptiCept Technologies

On Friday, April 12, OptiCept announced that the company has filed a patent application for a new application area. The patent is related to improving the organoleptic properties of fruit and vegetable products by using the company’s CEPT (Controlled Environment Pulsed electric fields Treatment) and VI (Vacuum Infusion) technology platforms. If approved, we believe it will strengthen OptiCept's already strong technology position and potentially broaden its long-term product offering. However, the big picture of the investment story still relates to commercialization progress, on which we do not expect new patents to have a significant impact.

On Friday, April 12, OptiCept <a href="https://www.inderes.se/releases/opticept-files-patent-application-for-combined-pef-and-vi-treatment-of-fruit-and-vegetable-products">announced</a> that the company has filed a patent application for a new application area. The patent is related to improving the organoleptic properties of fruit and vegetable products by using the company&rsquo;s CEPT (Controlled Environment Pulsed electric fields Treatment) and VI (Vacuum Infusion) technology platforms. If approved, we believe it will strengthen OptiCept's already strong technology position and potentially broaden its long-term product offering. However, the big picture of the investment story still relates to commercialization progress, on which we do not expect new patents to have a significant impact.
Patent for a new application area
Following successful outcomes with pineapple chunks, OptiCept has filed a patent application for a new area of application for its technology platforms. The application includes a Pulsed Electric Field (PEF) step followed by a vacuum injection step, either in combination or separately, to soften fruit or vegetable products. In this process, the products are impregnated with fruit or vegetable juice to enhance their color and texture. According to the company, this technology can naturally enhance the organoleptic properties of products, making them more appealing to consumers through improved texture, consistency and color. With improved quality, customers can also increase margins on existing products and create new products.
The patent could pave the way for OptiCept to enter new market segments
In our opinion, the newly filed patent related to improving the organoleptic properties of fruit and vegetable products is of particular interest because, based on the announcement and our assessment, the new application can be used to serve the company's promising customers in the fruit and vegetable industry, such as Dole. OptiCept has previously announced that it is conducting pineapple trials in collaboration with Dole, and we interpret this patent application as a positive sign of progress in these trials. However, we acknowledge that it is difficult to assess the economic value of this patent until concrete commercial applications are developed and brought to market. Therefore, we view the patent as a long-term option as part of the company's value and it does not lead to any immediate changes in our estimates, target price and/or recommendation.